«The Eurasian Congress of Internal Medicine»

Chairperson:
E.I. Tarlovskaya (Russia, Nizhny Novgorod)

• Itsenko-Cushing syndrome
  G.A. Manushakyan (Russia, Moscow)
• Renal artery stenosis and kidney prolapse
  A.V. Rodionov (Russia, Moscow)
• Thyrotoxicosis
  O.S. Fedorova (UAE, Dubai)
• Acute nephritic syndrome
  M.M. Batyushin (Russia, Rostov-on-Don)
• Primary aldosteronism
  E.I. Tarlovskaya (Russia, Nizhny Novgorod)
• Angioprotection: additional possibilities of antihypertensive therapy
  N.A. Koziolova (Russia, Perm)

Chairperson:
I.V. Fomin (Russia, Nizhny Novgorod)

• Recurrent pericarditis: breakthrough discoveries in pathogenesis and therapy
  A.G. Arutyunov (Armenia, Yerevan)
• CHF in Post-COVID
  I.V. Fomin (Russia, Nizhny Novgorod)
• Screening possibilities for diagnosing sleep apnea in patients with supraventricular tachyarrhythmias
  A.M. Baimukanov (Moscow)
• Adverse cardiovascular events in patients with coronary microvascular dysfunction: prognostic markers
  K.V. Kopeva (Tomsk)
• Kidney injury in COVID-19 patinets
  Sopiko Dvalishvili (Tbilisi)
• Experience with the use of ruxolitinib in the treatment of obliterating bronchitis in adult patients after allogeneic hematopoietic stem cell transplantation
  E.A. Kulagin (Saint Petersburg)
• Bacterial infections in patients with liver cirrhosis and gastrointestinal bleeding
  D.I. Gavrilenko (Gomel)
• Elevated IL-6 levels and long-term prognosis in elderly and senile patients with CHF and anemia, and without anemia
  N.I. Solomakhina (Moscow), A.V. Dementieva (Moscow)
• The use of felodipine in the treatment of bevacizumab-induced arterial hypertension
  S.V. Khlyamov (Kursk)

Chairperson:
O.S. Fedorova (UAE, Dubai)

• Controversial issues of thyroidology and prerequisites for pseudodiagnosis
  M.A. Sviridonova (Russia, Moscow)
• Myths and mistakes in the diagnosis and treatment of gestational diabetes
  L.I. Ibragimova (Russia, Moscow)
• Myths and controversial issues in the treatment of osteoporosis
  S.S. Mirnaya (Russia, Moscow)
• Myths about adrenal disease
  A.I. Tsiberkin (Russia, Saint Petersburg)

Chairperson:
A.P. Rebrov (Russia, Saratov)

• Arthralgia in the post-COVID period?
  P.I. Novikov (Russia, Moscow)
• Gout – Best Practice 2023
  R.A. Bashkinov (Russia, Saint Petersburg)
• Rheumatoid arthritis – Best Practice 2023
  E.S. Melnikov (Russia, Saint Petersburg)
• Spondyloarthritis – Best Practice 2023
  A.P. Rebrov (Russia, Saratov)

Chairperson:
V.V. Salukhov (Russia, Saint Petersburg)

• Major breakthroughs in diabetology in 2023
  V.V. Salukhov (Russia, Saint Petersburg)
• Diabetes and polycystic ovary syndrome: Myth or reality?
  Sarantis LIvadas (Greece, Athens)
• What do we call Prediabetes and how are approaches to treatment changing?
  K.V. Ovsyanikov (Russia, Moscow)
• Painless myocardial ischemia in diabetes mellitus – a marker of sudden death
  N.P. Mitkovskaya (Belarus, Minsk)

Chairperson:
I.V. Sergienko (Russia, Moscow)

• When and how to examine young people for dyslipidemia?
  A.S. Alieva (Russia, Moscow)
• Hypertriglyceridemia in young patients
  M.V. Ezhov (Russia, Moscow)
• Should LDL be lowered by 3-4 mmol/l in a patient without a risk factor?
  I.V. Sergienko (Russia, Moscow)
• Familial lipid metabolism disorders and their treatment
  I.V. Sergienko (Russia, Moscow)

Chairperson:
I.G. Nikitin (Russia, Moscow)

• NAFLD: diagnostic issues
  I.G. Nikitin (Russia, Moscow)
• Role of ultrasound in the diagnosis of NAFLD
  E.I. Penyaeva (Russia, Yaroslavl)
• The impact of NAFLD on prognosis
  Sarantis LIvadas (Greece, Athens)
• First steps in the treatment of NAFLD
  N.V. Bakulina (Russia, Saint Petersburg)
• NAFLD and statins
  Ivana Bozic Antic (Serbia, Belgrade)

Chairperson:
N.Y. Grigoryeva (Russia, Nizhny Novgorod)

• Asymptomatic hyperuricemia – to treat or not to treat
  R.A. Bashkinov (Russia, Saint Petersburg)
• Hyperuricemia on diuretics, kidney risks
  M.A. Trubnikova (Russia, Sochi)
• Differential diagnosis with an increase in the level of uric acid
  E.S. Melnikov (Russia, Saint Petersburg)
• Leukemia and lymphoma – could uric acid be the first marker?
  N.Y. Grigoryeva (Russia, Nizhny Novgorod)
• The gold standard for the management of a patient with gout 2023
  U.K. Kamilova (Uzbekistan, Tashkent)

Chairperson:
M.M. Batyushin (Russia, Rostov-on-Don)

• Infectious complications of therapy with SGLT-2 inhibitors and methods for their correction
  V.V. Salukhov (Russia, Saint Petersburg)
• UTI – and CKD is there a link?
  M.M. Batyushin (Russia, Rostov-on-Don)
• New antibiotics in the treatment of UTIs
  A.G. Arutyunov (Armenia, Yerevan)

Chairperson:
A.G. Arutyunov (Armenia, Yerevan)

• Physical training in CKD
  M.M. Batyushin (Russia, Rostov-on-Don)
• Can physical exercises reduce LDL?
  I.V. Sergienko (Russia, Moscow)
• How important is breathing training for COPD and asthma?
  M.V. Boldina (Russia, Nizhny Novgorod)
• Physical training for CHF
  A.G. Arutyunov (Armenia, Yerevan)

Chairperson:
M.M. Batyushin (Russia, Rostov-on-Don)

• Normochromic anemia
  M.M. Batyushin (Russia, Rostov-on-Don)
• Hyperchromic anemia
  A.G. Arutyunov (Armenia, Yerevan)
• Hyperchromic anemia
  G.P. Arutyunov (Russia, Moscow)

Chairperson:
F.T. Ageev (Russia, Moscow)

• Evolution of ideas about the pathogenesis and treatment options for HFpEF
  F.T. Ageev (Russia, Moscow)
• Left atrium as the main driver of HFpEF
  A.G. Ovchinikov (Russia, Moscow)
• Therapy for heart failure across the spectrum of LV EF: the choice of drugs
  Y.M. Lopatin (Russia, Volgograd)